Purpose: To investigate the characteristics of HER2-positive breast cancer according to HER2 low (2+) or high (3+) classification using immunohistochemistry (IHC).
Methods: Data were collected from 205 HER2-positive breast cancer patients in the final assay, regardless of IHC ...
Purpose: According to the American Joint Committee on Cancer’s 8th Edition Manual, lobular carcinoma in situ (LCIS) is no longer considered a malignant disease, although it may be a precursor to the development of breast cancer. The present study aimed to evaluate the clinicopa...
Purpose: This study aimed to determine the clinicopathologic factors, including tumor elasticity, affecting neoadjuvant chemotherapy response in breast cancer.
Methods: Among 95 patients who received neoadjuvant chemotherapy for clinical stage IIa-IIIc primary breast cancer, 7...
If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of JBD. Since it is open access journal, the full text is freely available.
Please Sign up.
To submit a manuscript, please visit the J Breast Dis e-submission management system at http://submit.jbd.or.kr, read the Instructions for Authors, and log into the J Breast Dis e-submission system. For assistance with manuscript submission, please contact: jbd.editorial@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
